Drospirenone with ethinylestradiol – November 2024

• Brand names:
  • Yasmin®
  • Yaz®
• Pharmaceutical Company:
  • BAYER AUSTRALIA LTD
• Condition/Indication: Oral contraceptive Moderate acne vulgaris in women who seek oral contraception Premenstrual dysphoric disorder in women who have chosen oral contraceptives as their method of birth control
• Meeting Date: November 2024
• Public Summary Document (PSD) July 2024 November 2024 PBAC Meetings - (PDF 1MB)
• Public Summary Document (PSD) July 2024 November 2024 PBAC Meetings - (Word 436KB)

Related Public Summary Documents

• Drospirenone with ethinylestradiol – July 2024